Cingal injections for persistent front-of-knee pain
Part of Bones, joints & muscles clinical trials.
This trial tests whether Cingal™ knee injections can reduce pain and improve knee function in people with long-lasting anterior knee (front-of-knee) pain. It is mainly for adults who have tried usual non-surgery treatments for at least 6 weeks but still feel pain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 35 years old
- You have had front-of-knee pain for at least 2 months
- You were told you have anterior knee pain, and it did not improve after at least 6 weeks of usual treatment (like exercise/physio, activity changes, taping/bracing, or anti-inflammatory medicine)
- Your pain gets worse with at least two activities like squatting, running, stairs, or long sitting with bent knees
- Your knee X-ray does not show osteoarthritis or a fracture, and you have no likely meniscus or ligament injury
- You have no Cingal allergy, no knee injection in the last 3 months, and you can have a knee injection safely
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new knee injection called CX-011 to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be a good option if you have tried other treatments without enough relief.
This trial tests three types of injections (saline, sugar water, or a ligament repair agent) for people with knee arthritis and a partially injured inner knee ligament. It aims to see which injection works best for pain and function.
This study tests if an injection made from amniotic fluid can reduce knee pain and improve function in people with moderate knee osteoarthritis. The goal is to give a long-lasting alternative to steroid or gel shots.
This study tests whether platelet-rich plasma (a treatment made from your own blood) can reduce symptoms of knee osteoarthritis. It focuses on people with specific types of knee pain and X-ray findings, and compares against rules around current pain medicines and injections.
This trial tests a new stem cell treatment (NCR100) for knee osteoarthritis. It aims to see if the injection can reduce pain and improve knee function in people with moderate knee OA.
This trial tests adding a pain-relieving injection (a 'cocktail' of medicines) into the knee joint during surgery to fix a broken kneecap. The goal is to see if this extra injection helps reduce pain and improve recovery after the operation.
Hear when a new Anterior Knee Pain Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.